Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Finasteride effectively treats hair loss in transgender men with few side effects.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Finasteride forms three new products under acidic stress.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Ginseng and Albizia extracts help prevent hair thinning with age.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Transgender women on estrogen therapy can develop melasma and need proper skin care.